South Africa’s main stocks benchmark rose for a second day after U.K. health authorities approved a coronavirus vaccine developed by AstraZeneca and the University of Oxford, an inoculation that’s expected to support emerging economies’ efforts to fight the pandemic. The FTSE/JSE Africa All Share Index was up 1% as of 10:15 a.m. in Johannesburg, propelled higher by a rebound in shares of Naspers and its unit Prosus NV from Monday’s lows that followed a Chinese antitrust probe of companies including Tencent, where Prosus is the largest shareholder. Precious metal miners rose, with Anglo American Platinum Ltd. +2.9%, Impala Platinum Holdings Ltd. +1.5%, AngloGold Ashanti Ltd. +1.6% Gold Fields Ltd. +1.3%Spot Platinum up 0.8%; spot gold broadly neutral. The rand rose 0.3% to R14.6747 rand against the dollar. Foreign investors bought a net R0.29 billion of South African stocks according to the Johannesburg Stock Exchange.

Source: News 24 December 30, 2020 10:07 UTC